Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer
Our study indicated that the RBP signature could serve as a prognostic biomarker of EC and provided new insights into the chemoresistance of this disease.
Authors
- Yanan Guo (ORCID: https://orcid.org/0000-0002-1166-1504)
- Yuetong Li (ORCID: https://orcid.org/0009-0004-0320-0953)
- Pierlorenzo Pallante (ORCID: https://orcid.org/0000-0001-7319-684X)
- Xue Pan
- Chunyao Huang
- Kaiyuan Li (ORCID: https://orcid.org/0000-0001-5037-632X)
- Alfredo Tartarone (ORCID: https://orcid.org/0000-0002-0859-7847)
- Yujie Zhang (ORCID: https://orcid.org/0000-0002-4926-028X)
- Guoqing Zhang (ORCID: https://orcid.org/0000-0002-6832-5931)
- Xiangnan Li (ORCID: https://orcid.org/0000-0001-6157-8680)
- Junya Wang (ORCID: https://orcid.org/0000-0002-3424-7402)
- Shaowu Sun (ORCID: https://orcid.org/0009-0003-8325-7396)
Institutions
- Zhengzhou University (CN)
- Centro di Riferimento Oncologico della Basilicata (IT)
- Institute for Experimental Endocrinology and Oncology (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- National Research Council (IT)
- First Affiliated Hospital of Zhengzhou University (CN)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/tcr-2024-2561
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00